Volunteer Donate Get Help
 

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Copanlisib for Follicular Lymphoma

Published: September 14, 2017

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

The U.S. Food & Drug Administration (FDA) granted accelerated approval to copanlisib today for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least 2 prior tr ... More >>.


Treatment for Older Lymphoma Patients

Published: September 13, 2017

Author: Carlos Harrison

Source: Cancer Therapy Advisor

Because of factors such as advances in health care and the decreasing overall incidence of cancer, the number of people age 65 and older around the world is expected to be 1.6 billion by 2050, which is twice ... More >>.


AML Response Improved

Published: September 05, 2017

Author: James Nam, PharmD

Source: Oncology Nurse Advisor

Guadecitabine may aid treatment-naïve patients with acute myeloid leukemia (AML) in achieving composite complete responses (CCR), according to a study published in The Lancet Oncology.

... More >>.


FDA Approval of AML Therapy

Published: September 01, 2017

Source: Leukemia & Lymphoma Society

The steady march of progress in new treatments for patients with acute myeloid leukemia (AML), continues today with the U.S. Food & Drug Administration approval of gemtuzumab ozogamicin (Mylotarg). After ... More >>.


New Advance for Acute Lymphoblastic Leukemia

Published: August 17, 2017

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society applauds today's approval by the U.S. Food & Drug Administration (FDA) of inotuzumab ozogamicin (Besponsa) for the treatment of adults with relapsed or refractory B-ce ... More >>.


CAR T Cell Therapy for ALL

Published: August 16, 2017

Author: Paul W. and Holly A. Ewald, PhD

Source: Cancer Therapy Advisor

A U.S. Food & Administration (FDA) panel recently recommended that approval of CTL019 chimeric antigen receptor (CAR) T cell therapy for acute lymphoblastic leukemia (ALL)----see related article dat ... More >>.


New Target Therapy for AML

Published: August 01, 2017

Source: Leukemia & Lymphoma Society

Today marks another significant advance in the offensive against acute myeloid leukemia (AML), one of the most deadly blood cancers that takes more than 10,000 lives in the U.S. each year. The Leukemia & ... More >>.


Fundamental Change in Leukemia Treatment

Published: July 27, 2017

Source: University of Kent

Researchers have identified a new cell mechanism that could lead to a fundamental change in the diagnosis and treatment of leukemia. A team in the University of Kent's pharmacy school conducted a study that ... More >>.


Immunotherapy Takes Significant Step

Published: July 20, 2017

Author: Gwen Nichols, M.D.

Source: Leukemia & Lymphoma Society

Today is a very significant day in the progress toward cancer cures. An advisory committee of the U.S. Food & Drug Administration (FDA) unanimously recommended approval of a revolutionary new treatment f ... More >>.


Anti-CD19 CRT-Cells Effective in CLL

Published: July 18, 2017

Author: James Nam, PharmD

Source: Cancer Therapy Advisor

Evidence published in the Journal of Clinical Oncology demonstrates that anti-CD19 chimeric antigen receptor-modified T (CAR-T) cell therapy is highly effective in treating high-risk patients with c ... More >>.


©2015 Stephanie Robinson Foundation | Privacy Policy